Edition:
United Kingdom

Molecular Medicine SpA (MLMD.MI)

MLMD.MI on Milan Stock Exchange

0.46EUR
15 Dec 2017
Change (% chg)

€-0.01 (-1.67%)
Prev Close
€0.47
Open
€0.47
Day's High
€0.48
Day's Low
€0.46
Volume
7,819,835
Avg. Vol
4,250,008
52-wk High
€0.54
52-wk Low
€0.40

Summary

Name Age Since Current Position

Claudio Bordignon

67 2015 Chairman of the Board

Riccardo Palmisano

2015 Chief Executive Officer

Andrea Quaglino

2013 Director Administration Finance & Control

Silvia Pisante

Head of Legal Affairs & Corporate Governance

Gian Paolo Rizzardi

51 2015 General Manager

Cynthia Giuliani

53 2008 Director of Human Resources & General Services

Laura Villa

2015 Director of Investor Relations & Communication

Luca Alberici

Head of Business Development

Tiziano Andreoli

2016 Director of Information Technology

Germano Carganico

2017 Executive Director, Strategic Affairs

Antonio Lambiase

56 2007 Director of Clinical Development

Marco Manoni

2013 Director of Facility Planning & Design

Catia Traversari

2002 Director of Research

Alberto Carletti

57 2012 Non-Executive Director

Sabina Grossi

52 2007 Non-Executive Director

Alfredo Messina

82 2007 Non-Executive Director

Laura Ferro

Independent Director

Carlo Incerti

Independent Director

Mario Masciocchi

2013 Lead Independent Director

Elizabeth Robinson

60 Independent Director

Raffaella Ruggiero

2013 Independent Director

Didier Trono

2015 Independent Director

Biographies

Name Description

Claudio Bordignon

Prof. Claudio Bordignon serves as Chairman of the Board of Molecular Medicine S.p.A. since November 6, 2007. He was also Chief Executive Officer at the firm from November 6, 2007 to December 11, 2015. He also acts as the Chairman of the Scientific Advisory Board of the Company. He is Founder of the Company and Pioneer in genetic and molecular therapy. He has produced publications and holds several patents in this field, which constitute one of the parts of the intellectual property of Molecular Medicine SpA. He headed the genetic therapy program and the bone marrow transplant unit of Istituto Scientifico San Raffaele, where he previously served as Scientific Director. In July 2005, he was Founding Member of the Scientific Board of the European Research Council. He is Professor of Hematology at the Medicine Faculty of Universita Vita-Salute San Raffaele di Milano. He gained a Doctorate of Medicine in Medicine from the Universita degli Studi di Milano and conducted studies and research in various institutions in the United Sates.

Riccardo Palmisano

Andrea Quaglino

Mr. Andrea Quaglino serves as Director Administration Finance & Control of MOLECULAR MEDICINE S.P.A since August 2013. He brings over 13 years auditing experience gained in a Big Four where he held positions of increasing responsibility. He carried out his activity mainly in Italian Groups with foreign subsidiaries operating in the pharmaceutical and luxury retail fields. He was also involved in important IPO and private placement projects. Andrea Quaglino obtained his degree in Universita Cattolica del Sacro Cuore, Milano and is a Chartered Accountant and a registered Public Auditor.

Silvia Pisante

Gian Paolo Rizzardi

Dr. Gian Paolo Rizzardi serves as General Manager at Molecular Medicine S.p.A. He was Director of Research & Development of Molecular Medicine S.p.A. from July 2011. He has more than 15 years’ experience in research on immunotherapeutic strategies, particularly in the areas of HIV/AIDS and infectious diseases: he contributed to the HIV/AIDS field with important studies on HIV immune-pathogenesis and with the design and development of immunomodulatory therapeutic strategies. Working at the Company, he also developed experience in the fields of tumor homing peptides and of vascular targeting agents. He is Author of more than 60 peer-reviewed publications and, together with Mr. Giuseppe Pantaleo, won the Pfizer Prize for research in infectious diseases in 1999. He has served as University Lecturer of Internal Medicine, Immunology, Infectious Disease and Biotechnology in Italy, Switzerland and the United States. He gained a Doctorate of Medicine in Medicine from Universita degli Studi di Milano in 1991.

Cynthia Giuliani

Ms. Cynthia Marina Giuliani serves as Director of Human Resources & General Services at Molecular Medicine S.p.A. since February 2008. She has 20 years of experience in human resources, gained in multinational and biotech companies such as Roche and Liebert Hiross and, most recently, in BioXell. From 1988 to 1997, she worked for Roche in numerous human resources related functions. From 1998 to 2000, she worked as Consultant to a variety of companies. From 2000 to 2002, she worked for Liebert HIROSS SpA as its European Development Manager, focusing on the recruitment and continuing education of personnel. Finally, before joining the Company, she worked for Bioxell, another biotechnology company, as Human Resources Director, responsible for the management, development and organization of its human resources function. She gained a Bachelor of Arts in Literature from the University of the Witwatersrand.

Laura Villa

Ms. Laura Villa serves as Director of Investor Relations & Communication of MOLECULAR MEDICINE S.P.A since September 2015. She has over 10 years’ experience in financial communication and management of relations with the financial community and relevant regulatory authorities (Borsa Italiana and Consob), gained at Italian and multinational companies of the biomedical and biotechnology sectors (Sorin S.p.A., DiaSorin S.p.A., CTI BioPharma Corp.). Prior to her roles in Investor Relations she worked for over 5 years in Generali AM in asset and portfolio allocation related functions, responsible for management of global Life science sector specialized funds. Laura Villa holds a degree in Economics of Public Administrations and International Institutions from the Universita Commerciale Luigi Bocconi.

Luca Alberici

Tiziano Andreoli

Mr. Tiziano Andreoli serves as Director of Information Technology of MOLECULAR MEDICINE S.P.A since January 2016. He joined MolMed in 2011 and he’s always worked in IT groups in different roles with growing responsibilities, focusing his activities in governance and assessments, process and data flows, reverse engineering, software analysis, re-engineering and development. He holds a degree in Electronic Engineering from Universita degli studi di Brescia.

Germano Carganico

Dr. Germano Carganico serves as Executive Director, Strategic Affairs of Molecular Medicine S.p.A. He was Director of Business Development & Strategic Affairs at Molecular Medicine S.p.A. from October 22, 2015. Previously. he was General Manager of Research & Development and Operations at the firm from January 31, 2011. He was appointed General Manager of the Company on January 1, 2011. He also acts as General Manager and President of Fondazione Toscana Life Sciences. He previously held a number of positions, notably as Preclinical Development Director at Menarini Pharmaceutical Industries Group in Florence, where he also became Corporate Director Research & Development, which included responsibility for Global Regulatory Affairs. During his career, he has also gained experience in the market launch of pharmaceutical products. From 2003 to 2005, he was Chief Business Officer at Axxam Srl. He contributed to the establishment of Regulatory Pharma Net Srl and of Pharma Quality Europe Srl. He gained a degree in Chemistry from the Universita degli Studi di Milano.

Antonio Lambiase

Dr. Antonio Lambiase serves as Director of Clinical Development at Molecular Medicine S.p.A. since March 2007. He previously worked for over 15 years at Roche in the areas of oncology and hematology as Medical Responsible for Clinical Development of several biological and molecular targeted compounds, including cancer bio therapeutics, hematopoietic growth factors, and therapeutic monoclonal antibodies and antiangiogenesis agents. Before that, he spent three years as Research Fellow at the Medical Oncology Unit of National Cancer Institute of Milan. He gained a degree in Medicine from Universita degli Studi di Napoli Federico II and a Doctorate of Medicine in Medicine from Universita degli Studi di Napoli Federico II.

Marco Manoni

Mr. Marco Manoni serves as Director of Facility Planning & Design at Molecular Medicine S.p.A. since March 2013. He was a Director of Operations at Molecular Medicine S.p.A. from September 2011 to March 2013. He obtained a Bachelor of Science degree.

Catia Traversari

Dr. Catia Traversari, Ph.D. serves as Director of Research of Molecular Medicine S.p.A.. In January 2002, she was appointed Head of Cancer Therapy of the Company. Prior to this date, she held the position of Head of Cancer Immunotherapy and Gene Therapy in Genera SpA. She has over 15 years’ experience in tumor immunology and immunotherapy research. She was involved in the molecular cloning of the first human tumor antigen gene during her stage at the Ludwig Institute. She is Author of more than 50 publications and Inventor of several of the Company's technologies. She joined the San Raffaele Scientific Institute in 1991 and was among Founding Members of the Gene Therapy Program. Previously, she served as Visiting Scientist at the Ludwig Institute for Cancer Research in Brussels and as Research Associate at Istituto dei Tumori di Milano, one of the non-profit cancer research centers in Italy. She gained a Doctorate in Philosophy in Biology from Universita degli Studi di Milano.

Alberto Carletti

Sabina Grossi

Dr. Sabina Grossi serves as a Non-Executive Director of Molecular Medicine S.p.A. since November 6, 2007. She has been a Member of the Remuneration Committee of the Company since November 11, 2007. From 1991 to 1993, she acted as Assistant for the Mathematics Analysis course within Universita degli Studi di Roma La Sapienza. In the same period, she worked as Lecturer in Statistics at Scuola di Polizia Tributaria and as Financial Analyst for Ufficio Studi Azionario di Caboto SIM. From 1996 to 2004, she served as Head of Investors Relations of Luxottica Group. She has been Member of the Board of Directors of Luxottica Group SpA since 2003. She also sits on the Board of Directors of Oliver Twist Onlus since 2006 and, since 2009, she has been Chairman of the Board of OneSight Luxottica Group Foundation ONLUS. She is Chartered Accountant and Auditor. She graduated in Business Economics from Luiss Guido Carli Libera Universita Internazionale degli Studi Sociali.

Alfredo Messina

Mr. Alfredo Messina serves as a Non-Executive Director of Molecular Medicine S.p.A. since November 6, 2007. He served as Controller of the production division of Olivetti and then moved to Alitalia as Central Director of the Administration, Finance and Control division. He was also Director of Planning and Control of IRI. He joined Fininvest in 1990, first as General Manager, then as Managing Director of Administration and Control. He serves as First Vice Chairman of Mediolanum SpA, Chairman of Mediolanum Assicurazioni, Mediolanum Vita and Vacanze Italia. He is also Member of the Board of Directors of Mediaset SpA and Gestevision Telecinco SA. He is Member of the Board of Directors of PI distribuzione SpA and Quinta Communications SA. He studied Business Economics.

Laura Ferro

Carlo Incerti

Mario Masciocchi

Elizabeth Robinson

Raffaella Ruggiero

Didier Trono